André Muller

André Muller

Director/Board Member at CELLECTIS S.A.

Net worth: - $ as of 31/05/2026

62 year
Health Technology
Consumer Services

Profile

André C.
Muller
is currently Chairman at Chiron Investments AG.
The current roles also include Independent Director at Cellectis SA starting in 2025, Director at Idorsia Ltd. starting in 2026, and Director positions at Idorsia Pharmaceuticals US, Inc. and Idorsia (Shanghai) Pharmaceuticals Co., Ltd. Former roles include Chief Executive Officer at Idorsia Ltd. and Idorsia Pharmaceuticals Ltd. from 2024 to 2025, Independent Director at Carmat SA from 2020 to 2024, Director at Nxera Pharma Japan Co., Ltd., Chief Financial Officer & Executive Vice President at Actelion Ltd. from 2013 to 2017, and Chief Financial Officer at Pierre Fabre SA from 1994 to 2011.
Education includes an MBA from EM Lyon Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/12/2024 0 ( -.--% ) - $ 31/05/2026

André Muller active positions

CompaniesPositionStart
CELLECTIS S.A. Director/Board Member 26/06/2025
IDORSIA LTD Director/Board Member 06/05/2026
Chiron Investments AG
Chairman -
Idorsia Pharmaceuticals US, Inc.
Director/Board Member -
Idorsia (Shanghai) Pharmaceuticals Co., Ltd.
Director/Board Member -

Former positions of André Muller

CompaniesPositionEnd
IDORSIA LTD Chief Executive Officer 01/07/2025
Chief Executive Officer 01/07/2025
CARMAT SA Director/Board Member 25/06/2024
ACTELION Director of Finance/CFO 01/01/2017
░░░░░░ ░░░░░ ░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
See the detail of André Muller's experience

Training of André Muller

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

35

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Idorsia Pharmaceuticals US, Inc.

Health Technology

Idorsia (Shanghai) Pharmaceuticals Co., Ltd.

Health Technology

Chiron Investments AG

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!